Reuters logo
BRIEF-Adocia and Lilly announce successful completion of an insulin pump study with BioChaperone Lispro in people with type 1 diabetes
December 16, 2016 / 5:29 PM / a year ago

BRIEF-Adocia and Lilly announce successful completion of an insulin pump study with BioChaperone Lispro in people with type 1 diabetes

Dec 16 (Reuters) - Eli Lilly And Co :

* Adocia and Lilly announce successful completion of an insulin pump study with Biochaperone Lispro in people with Type 1 diabetes

* Biochaperone Lispro U100 and Humalog showed similar safety results and were well tolerated

* An accelerated absorption profile of Biochaperone Lispro U100 was observed across three insulin delivery devices tested

* Biochaperone Lispro U100 demonstrated statistically significant increase in insulin exposure

* Biochaperone Lispro was associated with a consistent pattern of improved response to mixed meal testing compared to Humalog

* Both Biochaperone Lispro and Humalog were similarly well tolerated Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below